Amicus Therapeutics, Inc.FOLDNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 170.13% |
| Q2 2025 | -14.29% |
| Q1 2025 | -241.99% |
| Q4 2024 | 346.50% |
| Q3 2024 | 60.00% |
| Q2 2024 | 68.75% |
| Q1 2024 | -38.77% |
| Q4 2023 | -64.71% |
| Q3 2023 | 53.33% |
| Q2 2023 | 16.67% |
| Q1 2023 | 9.41% |
| Q4 2022 | -65.58% |
| Q3 2022 | 42.86% |
| Q2 2022 | 30.00% |
| Q1 2022 | -0.47% |
| Q4 2021 | -57.16% |
| Q3 2021 | 0.00% |
| Q2 2021 | 24.00% |
| Q1 2021 | 8.26% |
| Q4 2020 | -9.00% |
| Q3 2020 | -25.00% |
| Q2 2020 | 42.86% |
| Q1 2020 | 0.37% |
| Q4 2019 | -46.38% |
| Q3 2019 | 33.33% |
| Q2 2019 | 35.71% |
| Q1 2019 | -51.35% |
| Q4 2018 | 55.95% |
| Q3 2018 | -154.55% |
| Q2 2018 | -17.86% |
| Q1 2018 | 34.88% |
| Q4 2017 | 37.68% |
| Q3 2017 | -102.94% |
| Q2 2017 | 12.82% |
| Q1 2017 | 11.36% |
| Q4 2016 | -33.33% |
| Q3 2016 | 17.50% |
| Q2 2016 | -14.29% |
| Q1 2016 | -2.94% |
| Q4 2015 | -6.25% |